Beckman Coulter

CD28-PE, CD28.2

#IM2071U · western blot

6
Citing papers
122
Combined citations
Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers4Immune Cell Function and Interaction3Immunotherapy and Immune Responses3Cancer Cells and Metastasis2Cytomegalovirus and herpesvirus research1CAR-T cell therapy research1Immune Response and Inflammation1Cancer, Stress, Anesthesia, and Immune Response1

Papers citing this product

1
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
Blood·2014·115 cit.·DOI
2
T‐lymphocyte subtyping: an early warning and a potential prognostic indicator of active cytomegalovirus infection in patients with sepsis
Immunology and Cell Biology·2022·7 cit.·DOI
3
Persistence of peripheral CD8 + CD28− T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer
British Journal of Cancer·2024·DOI
4
CD8 Τ κυτταρική απάντηση έναντι των αντιγόνων MAGE στον καρκίνο του πνεύμονα
2010·DOI
5
Peripheral CD8+CD28- T cell level reflects tumor immunity and could predict anti- HER2 based therapy response in metastatic breast cancer
Research Square·2022·DOI
6
Predictive Role of Peripheral Blood Lymphocyte And Cytokine Phenotypes in Patients with Operable Breast Cancer And Neoadjuvant Therapy: A Preliminary Study
Research Square·2024·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.